NEPHROS INC financial data

Symbol
NEPH on Nasdaq
Location
South Orange, NJ
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 06 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 513% % 14%
Quick Ratio 130% % -18%
Return On Equity 16% %
Return On Assets 12% %
Operating Margin 8.1% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 10,626,683 shares 0.78%
Common Stock, Shares, Outstanding 10,626,683 shares 0.78%
Entity Public Float $14,091,124 USD 35%
Common Stock, Value, Issued $11,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 10,612,012 shares 0.64%
Weighted Average Number of Shares Outstanding, Diluted 11,040,925 shares 4.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $17,930,000 USD 32%
Research and Development Expense $1,196,000 USD 39%
Operating Income (Loss) $1,445,000 USD 52%
Nonoperating Income (Expense) $63,000 USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $340,000 USD 86%
Income Tax Expense (Benefit) $3,000 USD
Net Income (Loss) Attributable to Parent $1,481,000 USD 84%
Earnings Per Share, Basic 0 USD/shares 50%
Earnings Per Share, Diluted 0 USD/shares 50%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $5,171,000 USD 110%
Accounts Receivable, after Allowance for Credit Loss, Current $2,661,000 USD 57%
Inventory, Net $2,738,000 USD -12%
Assets, Current $10,706,000 USD 46%
Property, Plant and Equipment, Net $119,000 USD -31%
Operating Lease, Right-of-Use Asset $1,094,000 USD -24%
Goodwill $759,000 USD 0%
Other Assets, Noncurrent $50,000 USD 0%
Assets $13,247,000 USD 28%
Accounts Payable, Current $936,000 USD 135%
Accrued Liabilities, Current $1,151,000 USD 257%
Liabilities, Current $2,467,000 USD 133%
Operating Lease, Liability, Noncurrent $761,000 USD -33%
Liabilities $3,241,000 USD 47%
Retained Earnings (Accumulated Deficit) $143,200,000 USD 1%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $10,006,000 USD 22%
Liabilities and Equity $13,247,000 USD 28%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $322,000 USD
Net Cash Provided by (Used in) Financing Activities $1,000 USD 50%
Common Stock, Shares Authorized 40,000,000 shares 0%
Common Stock, Shares, Issued 10,626,683 shares 0.78%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $321,000 USD
Interest Paid, Excluding Capitalized Interest, Operating Activities $1,000 USD 0%
Deferred Tax Assets, Valuation Allowance $20,031,000 USD -5%
Deferred Tax Assets, Gross $20,504,000 USD -5.2%
Operating Lease, Liability $1,136,000 USD -23%
Depreciation $17,000 USD 55%
Lessee, Operating Lease, Liability, to be Paid $1,261,000 USD -26%
Property, Plant and Equipment, Gross $1,170,000 USD 5%
Operating Lease, Liability, Current $375,000 USD 13%
Lessee, Operating Lease, Liability, to be Paid, Year Two $450,000 USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year One $450,000 USD 3.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $125,000 USD -44%
Lessee, Operating Lease, Liability, to be Paid, Year Three $251,000 USD -44%
Deferred Tax Assets, Operating Loss Carryforwards $15,628,000 USD -6.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four $251,000 USD -44%
Additional Paid in Capital $153,195,000 USD 0.23%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $8,000 USD 0%
Interest Expense $1,000 USD 0%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%